ArticleBMC anesthesiology2025
Back pain after atrial fibrillation ablation under propofol sedation with adaptive servo-ventilation: incidence, time course, efficacy of venous-closure devices, and related factors.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pain is a frequent but underrecognized complication following atrial fibrillation (AF) ablation. Although AF ablation is increasingly performed worldwide, non-cardiac complications, particularly musculoskeletal pain such as back pain, remain insufficiently investigated. Post-ablation back pain is commonly attributed to prolonged and rigid bed rest required to achieve hemostasis at the femoral venous puncture site. Venous-closure devices have recently been introduced, enabling earlier ambulation and less restrictive bed rest. We hypothesized that venous-closure device use is associated with a lower incidence of post-ablation back pain.
methodsWe retrospectively analyzed 615 consecutive patients who underwent AF ablation under deep propofol sedation with adaptive servo-ventilation at a single tertiary center. Hemostasis was achieved by either prolonged manual compression requiring overnight bed rest (conventional compression group, n = 312) or a venous-closure device allowing earlier mobilization (device-utilized group, n = 303). The incidence, timing, and temporal course of post-ablation back pain were systematically assessed. Multivariable regression analyses were performed to identify independent factors associated with back pain.
resultsBack pain occurred in 52.6% of patients in the conventional compression group. In contrast, the device-utilized group experienced significantly shorter enforced bed rest (3.4 ± 0.7 h vs. 18.0 ± 2.2 h) and a markedly lower incidence of back pain (23.4% vs. 52.6%, p < 0.001). Although the overall temporal pattern of pain onset was similar between groups, the incidence of back pain from the initiation of bed rest through the following morning was consistently lower in patients treated with a venous-closure device. Multivariable analysis identified younger age, absence of intraoperative pentazocine, a prior history of back pain, and non-use of a venous-closure device as independent factors associated with post-ablation back pain.
conclusionsPost-ablation back pain occurred in nearly half of patients undergoing AF ablation with conventional manual compression. Venous-closure device use was independently associated with a substantially lower incidence of back pain, likely through earlier and less restrictive mobilization. Nevertheless, back pain persisted in approximately one-quarter of patients despite device use, indicating a need for additional preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.